옴니앱 (OABI) 주가

옴니앱(OABI)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.47 (+0.68%), 시가총액 $0.29B, 52주 최저~최고 $1.25 ~ $2.20.

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company offers animal-based technologies include OmniRat, OmniChicken, and Omn

핵심 지표

• 현재가: $4.47 (+0.68%)
• 시가총액: $0.29B
• 52주 최저~최고: $1.25 ~ $2.20
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

옴니앱의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

옴니앱 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.75

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.92
• 순이익률: -1.88%
• 영업이익률: -0.54%

자주 묻는 질문